This article provides a detailed examination of Reverse Transcription Quantitative PCR (RT-qPCR) for liquid biopsy applications in oncology, tailored for researchers and drug development professionals.
Accurate gene expression analysis via qPCR is foundational to cancer research, yet a pervasive reliance on traditional reference genes like GAPDH and ACTB frequently leads to data distortion and irreproducible...
This article provides a comprehensive guide for researchers and drug development professionals on implementing MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) guidelines specifically for cancer biomarker validation.
This article provides a comprehensive overview of the critical role real-time quantitative PCR (qPCR) plays in the discovery and validation of transcriptional biomarkers for drug development and clinical diagnostics.
This article provides a comprehensive framework for researchers and drug development professionals to benchmark 3D-QSAR models against molecular docking results.
This article provides a thorough comparative analysis of two foundational 3D-QSAR methodologies: field-based and similarity-based approaches.
This article provides a detailed comparison of 2D and 3D Quantitative Structure-Activity Relationship (QSAR) models in the context of glioblastoma multiforme (GBM) therapeutics.
This article provides a comprehensive comparison of two cornerstone 3D-QSAR techniques—Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA)—in the context of cancer drug discovery.
This article provides a comprehensive guide for computational chemists and drug development professionals on optimizing Comparative Molecular Similarity Indices Analysis (CoMSIA) field combinations to enhance model performance.
Activity cliffs (ACs), where minute structural modifications cause drastic potency shifts, represent a significant source of prediction error and a central challenge for 3D-QSAR modeling in drug discovery.